Architha Reddy on Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
Architha Reddy, Speech Language Pathologist at Talking Tales Speech therapy Clinic, shared on LinkedIn:
”Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
Repetitive Transcranial Magnetic Stimulation (rTMS), when combined with Speech-Language Therapy (SLT), is emerging as an effective adjunct in the rehabilitation of post-stroke aphasia.
This non-invasive neuromodulation technique targets cortical language networks to facilitate neuroplasticity and optimize therapy outcomes.
Clinical Rationale
•Inhibitory low-frequency rTMS to right-hemisphere language homologues reduces maladaptive interhemispheric inhibition
•Excitatory rTMS over perilesional left-hemisphere regions supports language network reactivation
Therapy-Driven Outcomes
When paired with structured, task-specific SLT, patients demonstrate measurable gains in:
•Naming and word retrieval
•Auditory comprehension
•Repetition
•Spontaneous verbal output
Evidence Highlights
•Right pSTG ( posterior superior temporal gyrus) inhibition improves comprehension and repetition
•Combined rTMS + intensive SLT enhances perilesional activation and microstructural integrity
•Subacute patients show faster and more robust naming recovery than chronic cases
Clinical Takeaway
When applied using evidence-based protocols, rTMS enhances neuroplastic responsiveness to speech-language therapy, leading to more targeted and functionally meaningful language gains, including measurable improvements in Aphasia Quotient (AQ) scores on the WAB in both subacute and chronic post-stroke aphasia.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation